-Medtech_THAI_STUDIO_LAB_249_5668a625a9ad46978c78f22fdb7af040-620x480.jpg "Immunoglobulin eeplacement therapy not associated with reduced risk of serious infections in patients with CLL 2")
In patients with chronic lymphocytic leukemia (CLL), regular treatment with immunoglobulin replacement therapy was not associated with a reduced risk of serious infections requiring hospitalization, according to a study published in Blood Advances.
This is the first large, real-world study to follow patients with CLL who are regularly receiving immunoglobulin replacement. Given its high cost and variable use in clinical practice, this is a critical issue from a policy, economic, and clinical perspective.”
Sara Carrillo de Albornoz, lead study author, health economist and PhD candidate at Monash University, Australia
CLL, a common type of leukemia in adults, disrupts the body’s production of antibodies (immunoglobulin…
Disclaimer
We strive to uphold the highest ethical standards in all of our reporting and coverage. We 5guruayurveda.com want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.
Website Upgradation is going on. For any glitch kindly connect at 5guruayurveda.com
